Loading…

Optic gliomas: A reanalysis of the university of California, San Francisco experience

Thirty‐eight cases of optic gliomas seen at the University of California, San Francisco, were reviewed. Two patients died in the postoperative period and were excluded from the follow‐up analysis. Twentynine cases (76%) involved the optic chiasm, nine (24%) cases were confined to one optic nerve. Mo...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1987-10, Vol.60 (8), p.1847-1855
Main Authors: Wong, Jeffrey Y. C., Uhl, Valery, Wara, William M., Sheline, Glenn E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4809-cc5ab61e0bb704b26c297c8364c8ce847a051c26813a59302e884959cb94cd113
container_end_page 1855
container_issue 8
container_start_page 1847
container_title Cancer
container_volume 60
creator Wong, Jeffrey Y. C.
Uhl, Valery
Wara, William M.
Sheline, Glenn E.
description Thirty‐eight cases of optic gliomas seen at the University of California, San Francisco, were reviewed. Two patients died in the postoperative period and were excluded from the follow‐up analysis. Twentynine cases (76%) involved the optic chiasm, nine (24%) cases were confined to one optic nerve. Most tumors were slow growing and progressive although there were three cases of adult chiasmal gliomas which exhibited unusually aggressive behavior. The three cases are presented in detail. After a mean follow‐up period of 9.4 years, the 10‐year overall actuarial survival was 87%. Relapse‐free survival was 55% at 10 years. Chiasmal tumors had a poorer prognosis compared to optic nerve tumors with 56% of chiasmal tumors recurring versus 22% of optic nerve tumors. Radiotherapy was beneficial in chiasmal gliomas, initially improving vision in 35% (6/17) and decreasing recurrence from 86% (6/7) without radiation therapy to 45% (9/20) with radiation therapy. Optic gliomas are not benign, self‐limiting lesions, and therefore require treatment. Radiotherapy is effective in chiasmal gliomas and should be used early in the management of these tumors. No advantage to radiotherapy could be demonstrated for optic nerve gliomas, although the number of these cases analyzed was small.
doi_str_mv 10.1002/1097-0142(19871015)60:8<1847::AID-CNCR2820600829>3.0.CO;2-E
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_81005775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>81005775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4809-cc5ab61e0bb704b26c297c8364c8ce847a051c26813a59302e884959cb94cd113</originalsourceid><addsrcrecordid>eNqVkFGLEzEUhYMoa3f1Jwh5EHHBqTfJZJJ0RShjVxcWC-qC4MMlk81oZDpTk1btvzdDa0EfBJ_CzTn3cO5HSM1gygD4cwZGFcBK_pQZrRgweV7BTL9gulSz2fzqVVG_rd9xzaEC0Ny8FFOY1ssLXizukMlx-y6ZQNYLWYqP98lpSl_zqLgUJ-REVJIDYxNys1xvgqOfuzCsbJrROY3e9rbbpZDo0NLNF0-3ffjuYwqb3fhT2y60Q-yDfUbf255eRtu7kNxA_c-1j8H3zj8g91rbJf_w8J6Rm8vFh_pNcb18fVXPrwtXajCFc9I2FfPQNArKhleOG-W0qEqnnc_XWpDM8UozYaURwL3WpZHGNaZ0t4yJM_Jkn7uOw7etTxtc5Sa-62zvh21CnXlKpWQ2ftobXRxSir7FdQwrG3fIAEfoOGLDERv-ho4VoMYROmKGjn9CR4GA9RI5LnL6o0ONbbPyt8fsA-WsPz7oNjnbtXtiR5sSWoIcS7Z724_Q-d3_Nfxnwb8U8Qt6P6qW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81005775</pqid></control><display><type>article</type><title>Optic gliomas: A reanalysis of the university of California, San Francisco experience</title><source>EZB Electronic Journals Library</source><creator>Wong, Jeffrey Y. C. ; Uhl, Valery ; Wara, William M. ; Sheline, Glenn E.</creator><creatorcontrib>Wong, Jeffrey Y. C. ; Uhl, Valery ; Wara, William M. ; Sheline, Glenn E.</creatorcontrib><description>Thirty‐eight cases of optic gliomas seen at the University of California, San Francisco, were reviewed. Two patients died in the postoperative period and were excluded from the follow‐up analysis. Twentynine cases (76%) involved the optic chiasm, nine (24%) cases were confined to one optic nerve. Most tumors were slow growing and progressive although there were three cases of adult chiasmal gliomas which exhibited unusually aggressive behavior. The three cases are presented in detail. After a mean follow‐up period of 9.4 years, the 10‐year overall actuarial survival was 87%. Relapse‐free survival was 55% at 10 years. Chiasmal tumors had a poorer prognosis compared to optic nerve tumors with 56% of chiasmal tumors recurring versus 22% of optic nerve tumors. Radiotherapy was beneficial in chiasmal gliomas, initially improving vision in 35% (6/17) and decreasing recurrence from 86% (6/7) without radiation therapy to 45% (9/20) with radiation therapy. Optic gliomas are not benign, self‐limiting lesions, and therefore require treatment. Radiotherapy is effective in chiasmal gliomas and should be used early in the management of these tumors. No advantage to radiotherapy could be demonstrated for optic nerve gliomas, although the number of these cases analyzed was small.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19871015)60:8&lt;1847::AID-CNCR2820600829&gt;3.0.CO;2-E</identifier><identifier>PMID: 3652011</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Combined Modality Therapy ; Cranial Nerve Neoplasms - epidemiology ; Cranial Nerve Neoplasms - radiotherapy ; Female ; Follow-Up Studies ; Glioma - epidemiology ; Glioma - radiotherapy ; Humans ; Male ; Medical sciences ; Middle Aged ; Neurology ; Optic Chiasm ; Optic Nerve ; Optic Nerve Diseases - epidemiology ; Prognosis ; San Francisco ; Tumors of the nervous system. Phacomatoses</subject><ispartof>Cancer, 1987-10, Vol.60 (8), p.1847-1855</ispartof><rights>Copyright © 1987 American Cancer Society</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4809-cc5ab61e0bb704b26c297c8364c8ce847a051c26813a59302e884959cb94cd113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7385055$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3652011$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wong, Jeffrey Y. C.</creatorcontrib><creatorcontrib>Uhl, Valery</creatorcontrib><creatorcontrib>Wara, William M.</creatorcontrib><creatorcontrib>Sheline, Glenn E.</creatorcontrib><title>Optic gliomas: A reanalysis of the university of California, San Francisco experience</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Thirty‐eight cases of optic gliomas seen at the University of California, San Francisco, were reviewed. Two patients died in the postoperative period and were excluded from the follow‐up analysis. Twentynine cases (76%) involved the optic chiasm, nine (24%) cases were confined to one optic nerve. Most tumors were slow growing and progressive although there were three cases of adult chiasmal gliomas which exhibited unusually aggressive behavior. The three cases are presented in detail. After a mean follow‐up period of 9.4 years, the 10‐year overall actuarial survival was 87%. Relapse‐free survival was 55% at 10 years. Chiasmal tumors had a poorer prognosis compared to optic nerve tumors with 56% of chiasmal tumors recurring versus 22% of optic nerve tumors. Radiotherapy was beneficial in chiasmal gliomas, initially improving vision in 35% (6/17) and decreasing recurrence from 86% (6/7) without radiation therapy to 45% (9/20) with radiation therapy. Optic gliomas are not benign, self‐limiting lesions, and therefore require treatment. Radiotherapy is effective in chiasmal gliomas and should be used early in the management of these tumors. No advantage to radiotherapy could be demonstrated for optic nerve gliomas, although the number of these cases analyzed was small.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Combined Modality Therapy</subject><subject>Cranial Nerve Neoplasms - epidemiology</subject><subject>Cranial Nerve Neoplasms - radiotherapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glioma - epidemiology</subject><subject>Glioma - radiotherapy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Optic Chiasm</subject><subject>Optic Nerve</subject><subject>Optic Nerve Diseases - epidemiology</subject><subject>Prognosis</subject><subject>San Francisco</subject><subject>Tumors of the nervous system. Phacomatoses</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><recordid>eNqVkFGLEzEUhYMoa3f1Jwh5EHHBqTfJZJJ0RShjVxcWC-qC4MMlk81oZDpTk1btvzdDa0EfBJ_CzTn3cO5HSM1gygD4cwZGFcBK_pQZrRgweV7BTL9gulSz2fzqVVG_rd9xzaEC0Ny8FFOY1ssLXizukMlx-y6ZQNYLWYqP98lpSl_zqLgUJ-REVJIDYxNys1xvgqOfuzCsbJrROY3e9rbbpZDo0NLNF0-3ffjuYwqb3fhT2y60Q-yDfUbf255eRtu7kNxA_c-1j8H3zj8g91rbJf_w8J6Rm8vFh_pNcb18fVXPrwtXajCFc9I2FfPQNArKhleOG-W0qEqnnc_XWpDM8UozYaURwL3WpZHGNaZ0t4yJM_Jkn7uOw7etTxtc5Sa-62zvh21CnXlKpWQ2ftobXRxSir7FdQwrG3fIAEfoOGLDERv-ho4VoMYROmKGjn9CR4GA9RI5LnL6o0ONbbPyt8fsA-WsPz7oNjnbtXtiR5sSWoIcS7Z724_Q-d3_Nfxnwb8U8Qt6P6qW</recordid><startdate>19871015</startdate><enddate>19871015</enddate><creator>Wong, Jeffrey Y. C.</creator><creator>Uhl, Valery</creator><creator>Wara, William M.</creator><creator>Sheline, Glenn E.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19871015</creationdate><title>Optic gliomas: A reanalysis of the university of California, San Francisco experience</title><author>Wong, Jeffrey Y. C. ; Uhl, Valery ; Wara, William M. ; Sheline, Glenn E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4809-cc5ab61e0bb704b26c297c8364c8ce847a051c26813a59302e884959cb94cd113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Combined Modality Therapy</topic><topic>Cranial Nerve Neoplasms - epidemiology</topic><topic>Cranial Nerve Neoplasms - radiotherapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glioma - epidemiology</topic><topic>Glioma - radiotherapy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Optic Chiasm</topic><topic>Optic Nerve</topic><topic>Optic Nerve Diseases - epidemiology</topic><topic>Prognosis</topic><topic>San Francisco</topic><topic>Tumors of the nervous system. Phacomatoses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, Jeffrey Y. C.</creatorcontrib><creatorcontrib>Uhl, Valery</creatorcontrib><creatorcontrib>Wara, William M.</creatorcontrib><creatorcontrib>Sheline, Glenn E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, Jeffrey Y. C.</au><au>Uhl, Valery</au><au>Wara, William M.</au><au>Sheline, Glenn E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optic gliomas: A reanalysis of the university of California, San Francisco experience</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1987-10-15</date><risdate>1987</risdate><volume>60</volume><issue>8</issue><spage>1847</spage><epage>1855</epage><pages>1847-1855</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>Thirty‐eight cases of optic gliomas seen at the University of California, San Francisco, were reviewed. Two patients died in the postoperative period and were excluded from the follow‐up analysis. Twentynine cases (76%) involved the optic chiasm, nine (24%) cases were confined to one optic nerve. Most tumors were slow growing and progressive although there were three cases of adult chiasmal gliomas which exhibited unusually aggressive behavior. The three cases are presented in detail. After a mean follow‐up period of 9.4 years, the 10‐year overall actuarial survival was 87%. Relapse‐free survival was 55% at 10 years. Chiasmal tumors had a poorer prognosis compared to optic nerve tumors with 56% of chiasmal tumors recurring versus 22% of optic nerve tumors. Radiotherapy was beneficial in chiasmal gliomas, initially improving vision in 35% (6/17) and decreasing recurrence from 86% (6/7) without radiation therapy to 45% (9/20) with radiation therapy. Optic gliomas are not benign, self‐limiting lesions, and therefore require treatment. Radiotherapy is effective in chiasmal gliomas and should be used early in the management of these tumors. No advantage to radiotherapy could be demonstrated for optic nerve gliomas, although the number of these cases analyzed was small.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>3652011</pmid><doi>10.1002/1097-0142(19871015)60:8&lt;1847::AID-CNCR2820600829&gt;3.0.CO;2-E</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1987-10, Vol.60 (8), p.1847-1855
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_81005775
source EZB Electronic Journals Library
subjects Adult
Aged
Biological and medical sciences
Combined Modality Therapy
Cranial Nerve Neoplasms - epidemiology
Cranial Nerve Neoplasms - radiotherapy
Female
Follow-Up Studies
Glioma - epidemiology
Glioma - radiotherapy
Humans
Male
Medical sciences
Middle Aged
Neurology
Optic Chiasm
Optic Nerve
Optic Nerve Diseases - epidemiology
Prognosis
San Francisco
Tumors of the nervous system. Phacomatoses
title Optic gliomas: A reanalysis of the university of California, San Francisco experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A11%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optic%20gliomas:%20A%20reanalysis%20of%20the%20university%20of%20California,%20San%20Francisco%20experience&rft.jtitle=Cancer&rft.au=Wong,%20Jeffrey%20Y.%20C.&rft.date=1987-10-15&rft.volume=60&rft.issue=8&rft.spage=1847&rft.epage=1855&rft.pages=1847-1855&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/1097-0142(19871015)60:8%3C1847::AID-CNCR2820600829%3E3.0.CO;2-E&rft_dat=%3Cproquest_cross%3E81005775%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4809-cc5ab61e0bb704b26c297c8364c8ce847a051c26813a59302e884959cb94cd113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=81005775&rft_id=info:pmid/3652011&rfr_iscdi=true